(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 191.08% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 3.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.33%.
Asp Isotopes's revenue in 2025 is $4,581,523.On average, 3 Wall Street analysts forecast ASPI's revenue for 2025 to be $1,387,520,293, with the lowest ASPI revenue forecast at $1,333,107,733, and the highest ASPI revenue forecast at $1,428,329,714. On average, 3 Wall Street analysts forecast ASPI's revenue for 2026 to be $6,398,990,649, with the lowest ASPI revenue forecast at $6,148,067,861, and the highest ASPI revenue forecast at $6,587,228,696.
In 2027, ASPI is forecast to generate $10,180,295,953 in revenue, with the lowest revenue forecast at $9,781,393,060 and the highest revenue forecast at $10,479,932,688.